A common complement C3 variant is associated with protection against wet age-related macular degeneration in a Japanese population

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Yanagisawa, Suiho ^a   Kondo, Naoshi ^a   Miki, Akiko ^a   Matsumiya, Wataru ^a   Kusuhara, Sentaro ^a   Tsukahara, Yasutomo ^a   Honda, Shigeru ^a   Negi, Akira ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; COMPLEMENT COMPONENT 3 GENE; CONTROLLED STUDY; EYE PROTECTION; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; GENE LINKAGE DISEQUILIBRIUM; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; JAPAN; MIDDLE AGED; RETINA MACULA DEGENERATION; STATISTICAL MODEL;

COMPLEMENT COMPONENT C3;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLEMENT C3; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 83155164591     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028847     Document Type: Article

References (53)

1. Gehrs KM, Anderson DH, Johnson LV, Hageman GS, (2006) Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med 38: 450-471.
2. Coleman HR, Chan CC, Ferris FL III, Chew EY, (2008) Age-related macular degeneration. Lancet 372: 1835-1845.
3. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
4. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
5. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
6. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38: 458-462.
7. Maller J, George S, Purcell S, Fagerness J, Altshuler D, et al. (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38: 1055-1059.
8. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, et al. (2007) Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 16: 1986-1992.
9. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, et al. (2009) Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 17: 100-104.
10. Ennis S, Gibson J, Cree AJ, Collins A, Lotery AJ, (2010) Support for the involvement of complement factor I in age-related macular degeneration. Eur J Hum Genet 18: 15-16.
11. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561.
12. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, et al. (2007) Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 39: 1200-1201.
13. Spencer KL, Olson LM, Anderson BM, Schnetz-Boutaud N, Scott WK, et al. (2008) C3 R102G polymorphism increases risk of age-related macular degeneration. Hum Mol Genet 17: 1821-1824.
14. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, et al. (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314: 989-992.
15. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, et al. (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314: 992-993.
16. Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A, et al. (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40: 892-896.
17. Mori K, Gehlbach PL, Kabasawa S, Kawasaki I, Oosaki M, et al. (2007) Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population. Invest Ophthalmol Vis Sci 48: 5315-5319.
18. Kim NR, Kang JH, Kwon OW, Lee SJ, Oh JH, et al. (2008) Association between complement factor H gene polymorphisms and neovascular age-related macular degeneration in Koreans. Invest Ophthalmol Vis Sci 49: 2071-2076.
19. Ng TK, Chen LJ, Liu DT, Tam PO, Chan WM, et al. (2008) Multiple gene polymorphisms in the complement factor H gene are associated with exudative age-related macular degeneration in Chinese. Invest Ophthalmol Vis Sci 49: 3312-3317.
20. Kondo N, Bessho H, Honda S, Negi A, (2011) Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 118: 339-344.
21. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A, (2007) LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 144: 608-612.
22. Tam PO, Ng TK, Liu DT, Chan WM, Chiang SW, et al. (2008) HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH. Invest Ophthalmol Vis Sci 49: 2357-2365.
23. Kondo N, Bessho H, Honda S, Negi A, (2010) Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration. Eur J Hum Genet 18: 634-635.
24. Zerbib J, Richard F, Puche N, Leveziel N, Cohen SY, et al. (2010) R102G polymorphism of the C3 gene associated with exudative age-related macular degeneration in a French population. Mol Vis 16: 1324-1330.
25. Thakkinstian A, McKay GJ, McEvoy M, Chakravarthy U, Chakrabarti S, et al. (2011) Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 173: 1365-1379.
26. Goto A, Akahori M, Okamoto H, Minami M, Terauchi N, et al. (2009) Genetic analysis of typical wet-type age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese population. J Ocul Biol Dis Infor 2: 164-175.
27. Pei XT, Li XX, Bao YZ, Yu WZ, Yan Z, et al. (2009) Association of C3 gene polymorphisms with neovascular age-related macular degeneration in a chinese population. Curr Eye Res 34: 615-622.
28. Liu X, Zhao P, Tang S, Lu F, Hu J, et al. (2010) Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population. Retina 30: 1177-1184.
29. Arakawa S, Takahashi A, Ashikawa K, Hosono N, Aoi T, et al. (2011) Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet (in press).
30. Ioannidis JP, Ntzani EE, Trikalinos TA, (2004) 'Racial' differences in genetic effects for complex diseases. Nat Genet 236: 1312-1318.
31. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG, (2001) Replication validity of genetic association studies. Nat Genet 2001 29: 306-309.
32. Sun LD, Xiao FL, Li Y, Zhou WM, Tang HY, et al. (2011) Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet 43: 690-694.
33. Seddon JM, Sharma S, Adelman RA, (2006) Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 113: 260-266.
34. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
35. Wigginton JE, Cutler DJ, Abecasis GR, (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76: 887-893.
36. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
37. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, et al. (2006) FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34 (Web Server issue): W635-641.
38. Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
39. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437: 1299-1320.
40. Ricklin D, Hajishengallis G, Yang K, Lambris JD, (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
41. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, et al. (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29: 95-112.
42. Ding X, Patel M, Chan CC, (2009) Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 28: 1-18.
43. Scholl HP, Charbel Issa P, Walier M, Janzer S, Pollok-Kopp B, et al. (2008) Systemic complement activation in age-related macular degeneration. PLoS One 3: e2593.
44. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, et al. (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 50: 5818-5827.
45. Hecker LA, Edwards AO, Ryu E, Tosakulwong N, Baratz KH, et al. (2010) Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet 19: 209-215.
46. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119: 1417-1436.
47. Blom AM, Kask L, Ramesh B, Hillarp A, (2003) Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H. Arch Biochem Biophys 418: 108-118.
48. Bora PS, Sohn JH, Cruz JM, Jha P, Nishihori H, et al. (2005) Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol 174: 491-497.
49. Arvilommi H, (1974) Capacity of complement C3 phenotypes to bind on to mononuclear cells in man. Nature 251: 740-741.
50. Welch TR, Beischel L, Kleesattel A, (1990) Functional consequences of the genetic polymorphism of the third component of complement. J Pediatr 116: S92-S97.
51. Maruko I, Iida T, Saito M, Nagayama D, Saito K, (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144: 15-22.
52. Liu Y, Wen F, Huang S, Luo G, Yan H, et al. (2007) Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 245: 1441-1445.
53. Imamura Y, Engelbert M, Iida T, Freund KB, Yannuzzi LA, (2010) Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol 55: 501-515.